Lowering the 'bad' cholesterol in your blood enough can slow down or stop the buildup of plaque in your arteries, which is what causes heart disease.
From The End of Heart Disease in a SINGLE Dose? · videoSee the scientific wording
Lowering LDL cholesterol to a sufficient degree can slow or halt the progression of atherosclerotic cardiovascular disease.
Very strong evidence
3 good-quality studies support this claim.
What the research says
3 studies reviewedSupporting (3)
The Effect of Lipid-Lowering Therapy on Coronary Artery Plaque in East Asia Population
Systematic Review With Meta-AnalysisMeta-analysis2025
Lowering bad cholesterol with medication helped shrink artery plaque and made it more stable, especially when cholesterol levels were brought very low.
Systematic Review With Meta-AnalysisMeta-analysis2026
This study shows that drugs that lower bad cholesterol can shrink artery plaques and make them less dangerous, which supports the idea that lowering LDL helps prevent heart attacks and strokes.
Systematic Review With Meta-AnalysisMeta-analysis2012
People who naturally have lower bad cholesterol from birth have a much lower chance of heart attacks, so lowering cholesterol early and enough seems to protect the heart.
Contradicting (0)
No contradicting studies found yet
That doesn't mean it's settled — it just means no study has tested the opposite.
Quality-weighted scoring: we follow the GRADE framework — each study is rated High, Moderate, Low, or Very Low based on study design, methodology rigor, and risk of bias. A single high-quality RCT can outweigh several weaker observational studies.
Scores reflect study quality, not just count.
Too much bad cholesterol in the blood sticks to the walls of your arteries and builds up into waxy plaques. These plaques can narrow the arteries and sometimes burst, causing a heart attack or stroke. When you lower the bad cholesterol enough, less of it gets into the artery walls, so the plaques stop growing and even shrink. The plaques also become stronger and less likely to break apart. This slows down or stops the heart disease from getting worse.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 3 supporting studies
How Fit Body Science checks a claim
- 1
We isolate the claim
Health advice from videos, articles and studies is broken down into single, testable claims.
- 2
We find the research
Each claim is matched against peer-reviewed studies, with every source cited by DOI.
- 3
We grade the evidence
Studies are scored on methodology, statistical rigor, transparency and publication quality.
The fitness and health internet is full of confident claims. We check them against real research.
Every claim on this site is traced back to peer-reviewed studies, scored on methodology and reporting quality, and given a verdict you can audit yourself — sources, DOIs and all.
- Full evidence breakdown and mechanism chains
- Ask our AI anything about a claim or its studies
- Get notified when new research changes a verdict
Lowering the 'bad' cholesterol in your blood enough can slow down or stop the buildup of plaque in your arteries, which is what causes heart disease.
Mechanism
4 studiesBad cholesterol in the blood builds up on artery walls, making them narrow and dangerous. When we lower bad cholesterol a lot, the buildup stops and the plaques get stronger and even shrink. This helps prevent heart attacks and strokes.
Too much bad cholesterol in the blood sticks to the walls of your arteries and builds up into waxy plaques. These plaques can narrow the arteries and sometimes burst, causing a heart attack or stroke. When you lower the bad cholesterol enough, less of it gets into the artery walls, so the plaques stop growing and even shrink. The plaques also become stronger and less likely to break apart. This slows down or stops the heart disease from getting worse.
Lowering the concentration of LDL cholesterol in the blood reduces the number of LDL particles circulating in the bloodstream.
With fewer LDL particles in the blood, less LDL enters the arterial wall through the endothelium into the intima.
Reduced LDL accumulation in the intima lowers the amount of cholesterol retained and oxidized, dampening the local inflammatory response and reducing the formation of lipid-laden foam cells.
The diminished inflammation and lipid core reduce the release of matrix-degrading enzymes and increase collagen production, thereby thickening the fibrous cap over the plaque, making it more stable and less prone to rupture.
Net cholesterol efflux from the plaque exceeds influx, leading to a reduction in plaque volume and composition changes that result in regression of atheroma and a lower risk of cardiovascular events.
Evidence from Studies
Last searched 1mo ago
Supporting (3)
Community contributions welcome
The Effect of Lipid-Lowering Therapy on Coronary Artery Plaque in East Asia Population
Lowering bad cholesterol with medication helped shrink artery plaque and made it more stable, especially when cholesterol levels were brought very low.
Proprotein Convertase Subtilisin/Kexin Type 9 and Atherosclerotic Plaque Progression: A Systematic Review and Meta-Analysis of Intravascular Imaging Studies
This study shows that drugs that lower bad cholesterol can shrink artery plaques and make them less dangerous, which supports the idea that lowering LDL helps prevent heart attacks and strokes.
Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis.
People who naturally have lower bad cholesterol from birth have a much lower chance of heart attacks, so lowering cholesterol early and enough seems to protect the heart.
1 study stuck in processing — a maintainer can requeue it.
Contradicting (0)
Community contributions welcome
1 study has been processing far longer than a normal run. The pipeline may be stuck — a maintainer can requeue it, and the results will appear here once it finishes.
Score Breakdown
No multi-axis breakdown available yet. The overall Pro / Against score above is the best signal.
- No clinical evidence is available; the score reflects mechanistic plausibility only.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Systematic Review and Meta-Analysis of LDL-Lowering Therapies on Atherosclerotic Cardiovascular Disease Progression
Comprehensive search of RCTs comparing intensive LDL-lowering (e.g., statins, PCSK9 inhibitors) to placebo or standard care, with outcomes including cardiovascular events, imaging-based plaque progression, and mortality, followed by meta-analysis.
Double-Blind Randomized Trial of Intensive LDL Lowering vs. Standard Care for Atherosclerotic Plaque Progression
Randomized, double-blind, placebo-controlled trial enrolling adults with established atherosclerotic cardiovascular disease, randomized to intensive LDL-lowering therapy (e.g., high-dose statin plus ezetimibe) vs. standard care, with serial coronary CT angiography or intravascular ultrasound to measure plaque volume over 2-3 years, plus clinical cardiovascular events.
Prospective Cohort Study of LDL Cholesterol Levels and Atherosclerotic Cardiovascular Disease Progression
Prospective cohort of adults without baseline cardiovascular disease, with serial LDL measurements and imaging (e.g., carotid intima-media thickness or coronary calcium score) over 5-10 years, tracking progression and clinical events.
Case-Control Study of LDL Cholesterol Levels in Patients with Rapid vs. Slow Atherosclerotic Progression
Select cases with documented rapid progression of atherosclerotic cardiovascular disease (e.g., significant increase in plaque burden on imaging) and matched controls with stable disease; compare historical LDL levels and lipid-lowering treatment intensity.